174 related articles for article (PubMed ID: 36206324)
1. Anticholinergic co-prescribing in nursing home residents using cholinesterase inhibitors: Potential deprescribing cascade.
Gromek KR; Thorpe CT; Aspinall SL; Hanson LC; Niznik JD
J Am Geriatr Soc; 2023 Jan; 71(1):77-88. PubMed ID: 36206324
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated With Deprescribing Acetylcholinesterase Inhibitors in Older Nursing Home Residents With Severe Dementia.
Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Nace D; Thorpe JM; Thorpe CT
J Am Geriatr Soc; 2019 Sep; 67(9):1871-1879. PubMed ID: 31162642
[TBL] [Abstract][Full Text] [Related]
3. Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.
Niznik J; Zhao X; Jiang T; Hanlon JT; Aspinall SL; Thorpe J; Thorpe C
Drugs Aging; 2017 Dec; 34(12):925-939. PubMed ID: 29214512
[TBL] [Abstract][Full Text] [Related]
4. Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia.
Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Hanson LC; Nace D; Thorpe JM; Thorpe CT
J Am Geriatr Soc; 2020 Apr; 68(4):699-707. PubMed ID: 31769507
[TBL] [Abstract][Full Text] [Related]
5. Concomitant use of anticholinergics with acetylcholinesterase inhibitors in Medicaid recipients with dementia and residing in nursing homes.
Modi A; Weiner M; Craig BA; Sands LP; Rosenman MB; Thomas J
J Am Geriatr Soc; 2009 Jul; 57(7):1238-44. PubMed ID: 19467148
[TBL] [Abstract][Full Text] [Related]
6. An examination of three prescribing cascades in a cohort of older adults with dementia.
Trenaman SC; Bowles SK; Kirkland S; Andrew MK
BMC Geriatr; 2021 May; 21(1):297. PubMed ID: 33964882
[TBL] [Abstract][Full Text] [Related]
7. Patterns of oral bisphosphonate deprescribing in older nursing home residents with dementia.
Niznik JD; Aspinall SL; Hanson LC; Gilliam MA; Li X; Kelley CJ; Thorpe CT
Osteoporos Int; 2022 Feb; 33(2):379-390. PubMed ID: 34480586
[TBL] [Abstract][Full Text] [Related]
8. Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary.
Reeve E; Farrell B; Thompson W; Herrmann N; Sketris I; Magin PJ; Chenoweth L; Gorman M; Quirke L; Bethune G; Hilmer SN
Med J Aust; 2019 Mar; 210(4):174-179. PubMed ID: 30771226
[TBL] [Abstract][Full Text] [Related]
9. Frailty and Potentially Inappropriate Medication Use at Nursing Home Transition.
Maclagan LC; Maxwell CJ; Gandhi S; Guan J; Bell CM; Hogan DB; Daneman N; Gill SS; Morris AM; Jeffs L; Campitelli MA; Seitz DP; Bronskill SE
J Am Geriatr Soc; 2017 Oct; 65(10):2205-2212. PubMed ID: 28752589
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.
Mantri S; Fullard M; Gray SL; Weintraub D; Hubbard RA; Hennessy S; Willis AW
JAMA Neurol; 2019 Jan; 76(1):41-49. PubMed ID: 30285047
[TBL] [Abstract][Full Text] [Related]
11. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia.
Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD
Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360
[TBL] [Abstract][Full Text] [Related]
12. Impact of deprescribing AChEIs on aggressive behaviors and antipsychotic prescribing.
Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Nace D; Thorpe JM; Thorpe CT
Alzheimers Dement; 2020 Apr; 16(4):630-640. PubMed ID: 32052930
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey.
Chatterjee S; Mehta S; Sherer JT; Aparasu RR
Drugs Aging; 2010 Dec; 27(12):987-97. PubMed ID: 21087068
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic medicines use among older adults before and after initiating dementia medicines.
Narayan SW; Pearson SA; Litchfield M; Le Couteur DG; Buckley N; McLachlan AJ; Zoega H
Br J Clin Pharmacol; 2019 Sep; 85(9):1957-1963. PubMed ID: 31046175
[TBL] [Abstract][Full Text] [Related]
15. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs.
Gill SS; Mamdani M; Naglie G; Streiner DL; Bronskill SE; Kopp A; Shulman KI; Lee PE; Rochon PA
Arch Intern Med; 2005 Apr; 165(7):808-13. PubMed ID: 15824303
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of providers who prescribed only anticholinergic medications for overactive bladder in 2020.
Carr DN; Macharia A; Hacker MR; Winkelman WD
Am J Obstet Gynecol; 2023 Sep; 229(3):316.e1-316.e7. PubMed ID: 37244459
[TBL] [Abstract][Full Text] [Related]
17. Sex Differences in Antipsychotic and Benzodiazepine Prescribing Patterns: A Cohort Study of Newly Admitted Nursing Home Residents with Dementia in Ontario, Canada.
Maclagan LC; Maxwell CJ; Harris DA; Campitelli MA; Diong C; Lapane KL; Hogan DB; Rochon P; Herrmann N; Bronskill SE
Drugs Aging; 2020 Nov; 37(11):817-827. PubMed ID: 32978758
[TBL] [Abstract][Full Text] [Related]
18. Deprescribing research in nursing home residents using routinely collected healthcare data: a conceptual framework.
Thorpe C; Niznik J; Li A
BMC Geriatr; 2023 Aug; 23(1):469. PubMed ID: 37542226
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation of Statins in Veterans Admitted to Nursing Homes near the End of Life.
Thorpe CT; Sileanu FE; Mor MK; Zhao X; Aspinall S; Ersek M; Springer S; Niznik JD; Vu M; Schleiden LJ; Gellad WF; Hunnicutt J; Thorpe JM; Hanlon JT
J Am Geriatr Soc; 2020 Nov; 68(11):2609-2619. PubMed ID: 32786004
[TBL] [Abstract][Full Text] [Related]
20. Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.
Hoffmann F; van den Bussche H; Wiese B; Schön G; Koller D; Eisele M; Glaeske G; Scherer M; Kaduszkiewicz H
BMC Psychiatry; 2011 Dec; 11():190. PubMed ID: 22145796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
